Target Corporation — Form 10-Q Summary
Reporting period: Third quarter and nine months ended October 30, 2021. The request metadata says 2020 Q3, but the filing itself is Target’s Q3 2021 Form 10-Q; comparisons below use the prior-year periods ended October 31, 2020.
Business context and results
Target operates as a single U.S.-focused retail segment, selling through stores and digital channels. Nearly all revenue is generated in the United States. The company reported continued comparable-sales growth amid COVID-19-related shifts in consumer demand and supply-chain disruption.
| Metric | Q3 2021 | Q3 2020 | Nine months 2021 | Nine months 2020 |
|---|---|---|---|---|
| Total revenue | $25.652B (+13.3%) | $22.632B | $75.009B (+15.0%) | $65.222B |
| Operating income | $2.010B (+3.9%) | $1.935B | $6.851B (+45.7%) | $4.703B |
| Net earnings | $1.488B | $1.014B | $5.402B | $2.988B |
| Diluted GAAP EPS | $3.04 | $2.01 | $10.87 | $5.91 |
| Adjusted diluted EPS (non-GAAP) | $3.03 (+8.7%) | $2.79 | $10.37 (+53.7%) | $6.75 |
| Operating margin | 7.8% | 8.5% | 9.1% | 7.2% |
| Gross margin rate | 28.0% | 30.6% | 29.5% | 29.1% |
Q3 comparable sales rose 12.7%, driven by 12.9% higher transaction volume; average transaction amount declined 0.2%. Store-originated comparable sales grew 9.7%, and digitally originated comparable sales grew 28.9%. Digital sales represented 17.6% of sales, versus 15.7% a year earlier. Nine-month comparable sales increased 14.4%.
Cash flow, balance sheet and capital allocation
- Nine-month operating cash flow was $5.597B, down 20.5% from $7.044B. The decrease reflected higher inventory investment, lower accounts-payable leverage and $1.1B of higher income-tax payments, partly offset by stronger operating results.
- Nine-month capital expenditures were $2.483B, compared with $2.009B. Cash and cash equivalents were $5.753B at October 30, 2021, down from $5.996B a year earlier and $8.511B at fiscal year-end.
- Inventory was $14.958B, up from $12.712B a year earlier. Current assets were $22.576B and current liabilities $23.351B.
- Balance-sheet current and long-term debt and other borrowings totaled $12.762B. Long-term debt, including its current portion, had a carrying amount of $10.605B and fair value of $12.300B; that note figure excludes commercial paper, certain adjustments and lease liabilities. No commercial paper or revolving-credit-facility balances were outstanding during the reported periods.
- In October 2021, Target replaced its $2.5B revolving credit facility with a $3.0B unsecured facility expiring in October 2026. Management said liquidity was expected to be adequate for operations, investment, debt maturities, dividends and repurchases.
- Target repurchased $5.042B of stock and paid $1.116B in dividends during the nine-month cash-flow period. The board authorized a new $15B repurchase program in August 2021; Target reported $14.632B remaining under publicly announced programs at October 30.
Material changes, outlook and risks
- Q3 operating income grew more slowly than revenue, while gross margin contracted 2.6 percentage points. Target attributed Q3 margin pressure to higher merchandise and freight costs, inventory shrink, and increased distribution-center compensation and headcount. Historically low promotional and clearance markdowns and category mix partly offset these pressures.
- SG&A expense rate improved to 18.9% from 20.5%, reflecting leverage from revenue growth. Nine-month operating income and EPS benefited from comparisons with the prior year, which included a $512M debt-extinguishment loss.
- Nine-month 2021 results included a $335M pretax gain on the February sale of Dermstore, which generated $356M in cash proceeds. The gain was excluded from adjusted EPS; Dermstore historically represented less than 1% of consolidated revenue, operating income and net assets.
- Management described increasing supply-chain disruptions, including production and port delays, shortages of truckers and dockworkers, and transportation delays. Actions included ordering earlier, securing ocean freight routes and using more air transport. Target warned that inability to source and move inventory promptly could cause out-of-stocks and lost sales, and that these actions and disruptions increased costs.
- COVID-19 continued to affect category and channel mix; virtually all stores, digital channels and distribution centers had remained open. The filing provides no specific earnings or sales guidance. Management noted quarterly results are not necessarily indicative of full-year results because of seasonality.
- Management reported no material change in previously disclosed risk factors or market-risk exposures, and no material developments in previously reported legal proceedings. A multi-year migration of legacy systems supporting inventory, sales and supply-chain transactions was in progress; management concluded disclosure controls were effective at a reasonable-assurance level.
Important facts for investors to verify
- Confirm the period: the supplied filing is for the quarter ended October 30, 2021, not 2020 Q3.
- Assess whether margin pressure from freight, merchandise costs, shrink and supply-chain labor persists, and whether pricing or markdowns offset it.
- Track inventory growth, availability and operating cash flow, including the effect of working-capital requirements and tax payments.
- Review the distinction between GAAP and adjusted EPS, including the Dermstore gain and prior-year debt-extinguishment charge.
- Monitor the scale and pace of repurchases and dividends relative to cash generation, debt, and investment needs, as well as the disclosed supply-chain and systems-migration risks.